Wedbush Downgrades 2seventy bio to Neutral, Announces $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst David Nierengarten downgraded 2seventy bio (NASDAQ:TSVT) from Outperform to Neutral and set a price target of $2. The downgrade reflects a more cautious stance on the company's stock.
November 20, 2023 | 2:58 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wedbush downgraded 2seventy bio from Outperform to Neutral and set a price target of $2, indicating a cautious outlook on the stock.
Analyst downgrades typically lead to a negative short-term reaction in the stock price as they suggest a less favorable outlook on the company's future performance. The setting of a price target can also influence investor expectations and stock valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100